Company: BCS
Filing Date: 2025-07-29
Form Type: 6-K
Source: 0001654954-25-008608
Chunk: 53

Company: BARCLAYS PLC
Filing Date: 2025-07-29
Form: 6-K
Chunk 53
---
249m (December 2024: £1,782m) with substantially all of the potential effect impacting profit and loss rather than reserves.

#### Significant unobservable inputs
The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2024.

#### Fair value adjustments
Key balance sheet valuation adjustments are quantified below:

|                                                      | As at 30.06.25 | As at 31.12.24 |
|                                                      |             £m |             £m |
| Exit price adjustments derived from market bid-offer 
 spreads                                              |           -536 |           -542 |
| Uncollateralised derivative funding                  |             28 |             19 |
| Derivative credit valuation adjustments              |           -189 |           -184 |
| Derivative debit valuation adjustments               |            117 |            108 |

●

Exit price adjustments derived from market bid-offer spreads decreased by £6m to £(536)m.

●

Uncollateralised derivative funding increased by £9m to £28m on back of change in underlying moves in the exposure profile of the derivative portfolio in scope and input funding spreads.

●

Derivative credit valuation adjustments increased by £5m to £(189)m on back of change in underlying moves in the exposure profile of the derivative portfolio in scope and input credit spread.

●

Derivative debit valuation adjustments increased by £9m to £117m on back of change in underlying moves in the exposure profile of the derivative portfolio in scope and input Barclays Bank PLC credit spread.

#### Portfolio exemption
**The Group uses the portfolio exemption in IFRS 13 Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Financial instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date.

Unrecognised gains as a result of the use of valuation models using unobservable inputs

The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial